Birchmere Ventures

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

Aspinity, Inc. is a company based in Pittsburgh, Pennsylvania, that specializes in manufacturing reconfigurable analog modular processor (RAMP) chips designed for ultra-low-power electronics. These chips utilize neuromorphic all-analog integrated circuit technology to analyze raw, unstructured analog sensor data, identifying significant events while filtering out background noise before the data is digitized. By focusing on early cues, Aspinity's RAMP chips significantly reduce the need for higher power processing, optimizing power consumption in always-on, battery-operated sensing devices. This technology is applicable across various markets, including consumer, industrial, and biomedical sectors, enhancing functionalities such as voice activation, industrial machine health monitoring, and wearable health monitoring. Aspinity was incorporated in 2012 and aims to revolutionize the architecture of sensing devices through innovative power and data management solutions.

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

Ikos is delivering a flexible on-demand leasing service for investors and analyzing internal data to guide future client investments. It simplifies the rental experience for landlords and renters with their adaptive process that transparently connects people with homes they want and desire while helping landlords and renters make informed decisions. Ikos was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

Aspinity, Inc. is a company based in Pittsburgh, Pennsylvania, that specializes in manufacturing reconfigurable analog modular processor (RAMP) chips designed for ultra-low-power electronics. These chips utilize neuromorphic all-analog integrated circuit technology to analyze raw, unstructured analog sensor data, identifying significant events while filtering out background noise before the data is digitized. By focusing on early cues, Aspinity's RAMP chips significantly reduce the need for higher power processing, optimizing power consumption in always-on, battery-operated sensing devices. This technology is applicable across various markets, including consumer, industrial, and biomedical sectors, enhancing functionalities such as voice activation, industrial machine health monitoring, and wearable health monitoring. Aspinity was incorporated in 2012 and aims to revolutionize the architecture of sensing devices through innovative power and data management solutions.

LegalSifter builds simple, affordable artificial intelligence products that help people manage their legal obligations and opportunities. It uses natural language processing and machine learning to turn unstructured terms, conditions, and words into structured data and insights.

JazzHR is a recruitment software provider designed to assist growing companies in achieving their hiring objectives. The platform offers user-friendly and affordable tools that replace manual hiring tasks with automation, allowing hiring managers to efficiently recruit and select the right talent. JazzHR's features include candidate sourcing and employer branding, which streamline the entire recruitment process. By leveraging these capabilities, businesses can effectively enhance their hiring practices and expedite the recruitment of new employees.

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

ALung Technologies is a medical device manufacturing company based in Pittsburgh, Pennsylvania, founded in 1997. The company specializes in developing devices for gas exchange to treat acute and chronic respiratory disorders. Its primary product, the Hemolung Respiratory Assist System (RAS), functions as a dialysis-like alternative or supplement to mechanical ventilation, allowing physicians to effectively remove carbon dioxide from the blood without relying solely on the lungs. This technology aims to reduce the need for intubation and invasive ventilation, thereby improving patient outcomes. Additionally, ALung offers the Hattler Catheter, which facilitates the insertion of its gas exchange devices into the central venous bloodstream.

Ikos is delivering a flexible on-demand leasing service for investors and analyzing internal data to guide future client investments. It simplifies the rental experience for landlords and renters with their adaptive process that transparently connects people with homes they want and desire while helping landlords and renters make informed decisions. Ikos was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.

Encentiv Energy LLC operates a platform designed to enhance participation in energy efficiency programs for utilities, energy efficiency vendors, finance companies, and non-residential customers. The company's flagship product, Encentivizer, is a national incentive management platform that connects clients with local electric utility rebates and funding solutions for new construction and renovation projects. It provides actionable data that empowers manufacturers, energy efficiency professionals, and utilities to engage business customers effectively and promote energy-saving decisions. In addition to incentive management, Encentiv Energy offers energy advisory services and project financing to support its clients in achieving sustainable energy solutions. Founded in 2009 and based in Pittsburgh, Pennsylvania, Encentiv Energy was previously known as AllFacilities Energy Group, LLC before rebranding in 2013.

Identified Technologies offers its industrial customers with a mapping drone solution to increase project visibility and team productivity. Its integrated software and services take care of everything from FAA compliance and flight planning to advanced analytics. It was founded in 2013 and headquartered in Pittsburgh, Pennsylvania.

SubCentral, Inc. is a company that specializes in providing tools and services for the management of Software-as-a-Service (SaaS) products and applications. Founded in 2015 and headquartered in Pittsburgh, SubCentral offers a subscription management platform designed for small and mid-sized businesses. This platform enables organizations to discover, track, and manage their recurring cloud software subscriptions from a single central hub. Key features of SubCentral's services include SaaS access, provisioning, password management, analytics, usage monitoring, and billing tools. By streamlining the management of cloud software subscriptions, SubCentral aims to enhance productivity for its clients.

Containership, Inc. is a technology company based in Pittsburgh, Pennsylvania, that specializes in cloud-based solutions for container management. Established in 2015, it offers a Platform-as-a-Service that enables users to automate, scale, and deploy applications across various cloud environments and data centers. The company's open-source Docker hosting platform facilitates application deployment, cluster scheduling, and service discovery. Additionally, Containership provides a hosted service that includes features such as automated provisioning, marketplace integrations, load balancing, and cluster snapshots. This comprehensive approach allows businesses to efficiently manage their containerized applications and easily transition between different cloud providers.

Treatspace is a platform where they can post accurate, up-to-date, and verifiable facts about their practices. For patients, Treatspace is a site where they can find and follow trustworthy information about their doctors. It enables high-performance referral management, powers online patient engagement, and facilitates clinical collaboration. Treatspace changes the way primary care, specialty care, and hospital-based systems collaborate in closed-loop referral management and care coordination. The platform was founded in 2012 and is based in Pittsburgh, Pennsylvania, United States.

Identified Technologies offers its industrial customers with a mapping drone solution to increase project visibility and team productivity. Its integrated software and services take care of everything from FAA compliance and flight planning to advanced analytics. It was founded in 2013 and headquartered in Pittsburgh, Pennsylvania.

JazzHR is a recruitment software provider designed to assist growing companies in achieving their hiring objectives. The platform offers user-friendly and affordable tools that replace manual hiring tasks with automation, allowing hiring managers to efficiently recruit and select the right talent. JazzHR's features include candidate sourcing and employer branding, which streamline the entire recruitment process. By leveraging these capabilities, businesses can effectively enhance their hiring practices and expedite the recruitment of new employees.

NoWait, Inc. is a mobile platform based in Pittsburgh, Pennsylvania, that enhances the dining experience by connecting consumers with casual dining restaurants across the United States. Founded in 2010, the company offers a restaurant reservation application that allows users to join waitlists and manage reservations conveniently through their smartphones. The platform also provides restaurants with a comprehensive management tool for handling waiting lists and seating, enabling a seamless transition for diners from searching for a restaurant to getting in line with just a few taps. As of February 2017, NoWait operates as a subsidiary of Yelp Inc.

ALung Technologies is a medical device manufacturing company based in Pittsburgh, Pennsylvania, founded in 1997. The company specializes in developing devices for gas exchange to treat acute and chronic respiratory disorders. Its primary product, the Hemolung Respiratory Assist System (RAS), functions as a dialysis-like alternative or supplement to mechanical ventilation, allowing physicians to effectively remove carbon dioxide from the blood without relying solely on the lungs. This technology aims to reduce the need for intubation and invasive ventilation, thereby improving patient outcomes. Additionally, ALung offers the Hattler Catheter, which facilitates the insertion of its gas exchange devices into the central venous bloodstream.

JazzHR is a recruitment software provider designed to assist growing companies in achieving their hiring objectives. The platform offers user-friendly and affordable tools that replace manual hiring tasks with automation, allowing hiring managers to efficiently recruit and select the right talent. JazzHR's features include candidate sourcing and employer branding, which streamline the entire recruitment process. By leveraging these capabilities, businesses can effectively enhance their hiring practices and expedite the recruitment of new employees.

NoWait, Inc. is a mobile platform based in Pittsburgh, Pennsylvania, that enhances the dining experience by connecting consumers with casual dining restaurants across the United States. Founded in 2010, the company offers a restaurant reservation application that allows users to join waitlists and manage reservations conveniently through their smartphones. The platform also provides restaurants with a comprehensive management tool for handling waiting lists and seating, enabling a seamless transition for diners from searching for a restaurant to getting in line with just a few taps. As of February 2017, NoWait operates as a subsidiary of Yelp Inc.

ALung Technologies is a medical device manufacturing company based in Pittsburgh, Pennsylvania, founded in 1997. The company specializes in developing devices for gas exchange to treat acute and chronic respiratory disorders. Its primary product, the Hemolung Respiratory Assist System (RAS), functions as a dialysis-like alternative or supplement to mechanical ventilation, allowing physicians to effectively remove carbon dioxide from the blood without relying solely on the lungs. This technology aims to reduce the need for intubation and invasive ventilation, thereby improving patient outcomes. Additionally, ALung offers the Hattler Catheter, which facilitates the insertion of its gas exchange devices into the central venous bloodstream.

CyOptics, Inc. is engaged in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, which are essential for access, metro, and long-haul communications systems. The company's product offerings include planar lightwave circuits (PLCs) tailored for optical networks utilized in telecommunications and defense sectors. Additionally, CyOptics produces various optical components such as transmitters, receivers, and modulators, which serve as critical technology enablers for manufacturers of optical sub-assemblies and modules. The company also provides contract design, foundry, and packaging services, alongside radio frequency and optical design, wafer fabrication, and automated assembly and testing services for both telecom and non-telecom applications. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, a silicon PLC fabrication site in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

ALung Technologies is a medical device manufacturing company based in Pittsburgh, Pennsylvania, founded in 1997. The company specializes in developing devices for gas exchange to treat acute and chronic respiratory disorders. Its primary product, the Hemolung Respiratory Assist System (RAS), functions as a dialysis-like alternative or supplement to mechanical ventilation, allowing physicians to effectively remove carbon dioxide from the blood without relying solely on the lungs. This technology aims to reduce the need for intubation and invasive ventilation, thereby improving patient outcomes. Additionally, ALung offers the Hattler Catheter, which facilitates the insertion of its gas exchange devices into the central venous bloodstream.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

Inspired Technologies, based in North Huntingdon, PA, is a commercial-stage medical device company specializing in respiratory products for patients with chronic obstructive pulmonary disease (COPD). The company develops innovative solutions such as personal oxygen portables featuring SmartDose technology, which continuously monitors a user's breath rate and automatically adjusts oxygen delivery based on their activity level. Additionally, Inspired Technologies provides Clinical Oxygen Dose Recorders that allow healthcare providers to monitor patient responses and optimize performance in real time. Their offerings also include Viaspire SD Card Software, which facilitates the upload and analysis of patient data from SmartDose units, enhancing the management of oxygen therapy for COPD patients.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

Inspired Technologies, based in North Huntingdon, PA, is a commercial-stage medical device company specializing in respiratory products for patients with chronic obstructive pulmonary disease (COPD). The company develops innovative solutions such as personal oxygen portables featuring SmartDose technology, which continuously monitors a user's breath rate and automatically adjusts oxygen delivery based on their activity level. Additionally, Inspired Technologies provides Clinical Oxygen Dose Recorders that allow healthcare providers to monitor patient responses and optimize performance in real time. Their offerings also include Viaspire SD Card Software, which facilitates the upload and analysis of patient data from SmartDose units, enhancing the management of oxygen therapy for COPD patients.

Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

CyOptics, Inc. is engaged in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, which are essential for access, metro, and long-haul communications systems. The company's product offerings include planar lightwave circuits (PLCs) tailored for optical networks utilized in telecommunications and defense sectors. Additionally, CyOptics produces various optical components such as transmitters, receivers, and modulators, which serve as critical technology enablers for manufacturers of optical sub-assemblies and modules. The company also provides contract design, foundry, and packaging services, alongside radio frequency and optical design, wafer fabrication, and automated assembly and testing services for both telecom and non-telecom applications. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, a silicon PLC fabrication site in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Protez Pharmaceuticals is a medical research company that discovers, develops, and commercializes antibiotics for difficult-to-treat hospital-based infections. The company focuses on differentiated intravenous and oral small molecule antibiotics to address bacterial resistant, and chronic or recurrent infections. Protez Pharmaceuticals was founded by Christopher M. Cashman in 2003 and is headquartered in Malvern, Pennsylvania.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Entigo is a company that specializes in enterprise warranty chain management solutions, offering a suite of products designed to streamline warranty processes for businesses. Its flagship product, Entigo Warranty, allows organizations to manage warranty processing efficiently, while Entigo Catalyst provides strategic evaluations of existing warranty operations. The company also offers a range of consulting services, including project management, warranty process reengineering, systems integration, and training. These solutions automate key functions such as registration and claims handling, improving the speed of claims adjudication and problem resolution. By providing analytics and reporting capabilities, Entigo helps businesses enhance product quality and reduce warranty costs. The company's systems are designed to minimize errors and inefficiencies, ensuring seamless integration with warranty chain partners. Serving a diverse clientele, including Fortune 500 manufacturers in various industries such as automotive, aerospace, and electronics, Entigo aims to simplify warranty management and support operational excellence. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to delivering innovative solutions that meet the evolving needs of its customers.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

TissueInformatics.Inc™ is the only company providing Tissue Information Solutions™, a comprehensive, fully integrated set of tools to quickly and easily capture, analyze, search and mine the rich data present in tissue. Tissue Information Solutions create new knowledge and bring greater speed and accuracy for better decisions in scientific research and development. Each customizable Tissue Information Solution is based upon TissueInformatics' unique Quantf(x)™ technology platform. Quantf(x)™ is applied to automatically identify and quantify any feature ( f ) of interest in a customer-specified tissue investigation ( x ). Quantf(x)™ takes tissue information to the next power by replacing existing manual processes that are subjective and time-consuming. Archived, high-resolution images are linked with quantitative descriptions of tissue structure and function in a flexible data format for analysis and correlation with other biological data. TissueInformatics.Inc™ pioneered "tissue informatics," the segment of bioinformatics focused on tissue information. Tissue information is comprised of the components and organizational patterns of tissue features – human, plant or animal – that can be made visible, objectively analyzed and recorded.

LogicLibrary, Inc. specializes in providing software and services that enable enterprises to manage and reuse software development assets. The company's technology facilitates the creation, migration, and integration of enterprise applications tailored for service-oriented architecture and web services. Key offerings include Logiscan, a code-scanning tool designed to enhance security throughout the software development lifecycle, and Logidex, a mapping and discovery engine that visually represents enterprise application environments. This encompasses not only executables and their associated artifacts but also knowledge assets such as best practices and design patterns. LogicLibrary also provides implementation and training services, along with strategic planning for service-oriented architecture and asset reuse initiatives. Founded in 2000 and headquartered in Pittsburgh, Pennsylvania, the company has additional offices in Minnesota and California and serves a range of Global 2000 enterprises. It has established partnerships with major industry players, including Microsoft and IBM.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Cerebellum Software, developer technology for linking e-business applications with corporate data systems.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Neolinear is a software developer specializing in analog and mixed-signal silicon design. The company's technology plays a crucial role in the development of mixed-signal chips that integrate both analog and digital circuitry, primarily targeting the consumer and communications markets. As semiconductors become more differentiated by their analog components, Neolinear's rapid analog design solutions are essential for enhancing the performance and functionality of these chips.

Webmedx, Inc. provides medical documentation services. It offers transcription outsourcing solutions to support the clinical documentation needs of hospitals and clinics; and Webmedx Enterprise, a Web-native document and content management technology platform, which transforms physician dictation into clinical documentation possible for patient care and usable content for electronic health record applications. The company also provides QualityAnalytics, an Enterprise clinical documentation platform, which makes reporting quality measures easier and automates data abstraction for various types of queries, including Medicare's Recovery Audit Recovery (RAC) program. Webmedx, Inc. was formerly known as RadNet Corporation. The company was founded in 1996 and is headquartered in Atlanta, Georgia with additional offices in Nashville, Tennessee; Pittsburgh, Pennsylvania; and Spokane, Washington.

Safeguard Interactive provides online data storage and management solutions for consumers. It is based in Pittsburgh, Pennsylvania.

FreeMarkets is a company that specializes in providing software, services, and solutions for the global supply management market. Founded in 1995 by Glen T. Meakem, the company focuses on enhancing sourcing and supply management processes for businesses. FreeMarkets offers a range of solutions designed to help organizations lower costs and mitigate supply risks. These include tools for customized business-to-business online auctions, as well as a portfolio of sourcing solutions such as FreeMarkets GSM Solutions, FreeMarkets FullSource, FreeMarkets QS, FreeMarkets ES, and FreeMarkets Spend Visibility Solution. The company was originally known as Online Markets Corporation and underwent several name changes before adopting its current name in 1999.